agilon health, inc. (NYSE:AGL - Get Free Report) has received an average rating of "Hold" from the twenty brokerages that are currently covering the company, Marketbeat.com reports. Two research analysts have rated the stock with a sell rating, fourteen have assigned a hold rating and four have given a buy rating to the company. The average twelve-month target price among analysts that have issued ratings on the stock in the last year is $8.03.
A number of research analysts recently commented on AGL shares. Evercore ISI lowered their price target on agilon health from $7.00 to $4.00 and set an "in-line" rating on the stock in a report on Tuesday. Royal Bank of Canada reaffirmed an "outperform" rating and set a $8.00 price objective on shares of agilon health in a report on Wednesday, August 7th. Deutsche Bank Aktiengesellschaft decreased their price objective on agilon health from $5.00 to $4.00 and set a "hold" rating on the stock in a report on Friday, August 9th. Bank of America cut agilon health from a "buy" rating to an "underperform" rating and set a $3.00 price objective on the stock. in a report on Wednesday, October 2nd. Finally, Benchmark reaffirmed a "buy" rating and set a $9.00 price objective on shares of agilon health in a report on Thursday, August 8th.
Check Out Our Latest Stock Analysis on agilon health
Insider Buying and Selling at agilon health
In other agilon health news, CEO Steven Sell acquired 20,000 shares of the business's stock in a transaction on Thursday, September 12th. The shares were bought at an average price of $3.36 per share, with a total value of $67,200.00. Following the transaction, the chief executive officer now directly owns 67,590 shares of the company's stock, valued at $227,102.40. The trade was a 0.00 % increase in their position. The purchase was disclosed in a document filed with the SEC, which is available at this link. 3.20% of the stock is currently owned by corporate insiders.
Hedge Funds Weigh In On agilon health
Several hedge funds have recently bought and sold shares of the business. City State Bank bought a new position in shares of agilon health during the 3rd quarter worth $52,000. Inspire Investing LLC bought a new position in shares of agilon health during the 3rd quarter worth $414,000. SG Americas Securities LLC bought a new position in shares of agilon health during the 3rd quarter worth $92,000. Healthcare of Ontario Pension Plan Trust Fund bought a new position in shares of agilon health during the 2nd quarter worth $1,849,000. Finally, Sanctuary Advisors LLC bought a new position in shares of agilon health during the 2nd quarter worth $197,000.
agilon health Price Performance
NYSE AGL traded down $0.10 during trading hours on Friday, reaching $3.22. The company's stock had a trading volume of 3,050,954 shares, compared to its average volume of 4,966,783. The firm's 50-day moving average price is $4.13 and its 200-day moving average price is $5.31. The company has a quick ratio of 1.36, a current ratio of 1.36 and a debt-to-equity ratio of 0.04. agilon health has a 1 year low of $2.99 and a 1 year high of $20.37. The company has a market capitalization of $1.32 billion, a price-to-earnings ratio of -4.41 and a beta of 0.54.
agilon health (NYSE:AGL - Get Free Report) last posted its quarterly earnings results on Tuesday, August 6th. The company reported ($0.07) EPS for the quarter, hitting analysts' consensus estimates of ($0.07). agilon health had a negative return on equity of 29.91% and a negative net margin of 5.57%. The company had revenue of $1.48 billion for the quarter, compared to analysts' expectations of $1.56 billion. During the same period in the previous year, the firm earned ($0.04) EPS. The firm's revenue was up 38.7% compared to the same quarter last year. On average, equities research analysts predict that agilon health will post -0.32 EPS for the current fiscal year.
About agilon health
(
Get Free Reportagilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.
See Also
Before you consider agilon health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and agilon health wasn't on the list.
While agilon health currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
